Cited by 8Antifungal resistance and susceptibilityHIV/AIDS oral health manifestationsOral Health Pathology and Treatment

Human Oropharyngeal Candidiasis: From Etiology to Current Treatment

Open access
Qadir, Muhammad Imran, Bashir, Hina, Ahmad, Muhammad Hammad·2023·Critical Reviews in Immunology

Abstract

Oral candidiasis is a common but most harmful oral cavity infection caused by yeast-like fungus, this condition is called Oropharyngeal candidiasis. There are various species of candida that are responsible for oral cavity fungal infection including mostly Candida albicans. Different candida infections may be acute and chronic. Cell-mediated immunity, humoral immunity, and granulocytes are the immune factors for the cause of this infection. Different antifungal drugs like nystatin, fluconazole, and amphotericin are used to treat oral cavity fungal infections.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1615/critrevimmunol.2023049730

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

1 of the 96 references couldn’t be matched to a known paper.

Research works printed but not linked: 30

  1. Liguori G, Di Onofrio V, Gallé F, Lucariello A, Albano L, Catania MR, Guida M. Candida albicans identification: Comparison among nine phenotypic systems and a multi- plex PCR. J Prev Med Hyg. 2010;51(3):121-4.
  2. Hanif M, Shoaib MH, Yousuf RI, Sattar S, Nadeem M, Hussain L, Zia MU, Muhammad IN, Uzair M, Qadir I. Formulation development of intermediate release Nime- sulide tablets by CCRD for IVIVC studies. Pak J Pharm Sci. 2014;27(4):785-92.
  3. Massud A, Ishfaq B, Ahmed B, Qadir MI. Formulation, development and optimization of propranolol mucoadhe- sive bilayer tablets by using central composite design and its in-vitro studies. Lat Am J Pharm. 2015;34(8):1637-44.
  4. Massud A, Umar MH, Ahmed B, Qadir MI. Formu- lation and evaluation of sustained release bilayer tab- lets of naproxen and tizanidine. Lat Am J Pharm. 2021;40(2):390-7.
  5. Qadir MI. Nanopreparations for better drug delivery. Pak J Pharm Sci. 2017;30(6):2301-9.
  6. Zafar S, Rasul A, Iqbal MS, Rasool M, Ahmed B, Qadir MI. Nanobiotechnology: Cradle for revolution in drug carrier systems. Pak J Pharm Sci. 2021;34(1):185-96.
  7. Qadir MI. QadirVID-19: A fusion inhibitor against novel Coronavirus-2019 for specific management of COVID-19. Pak J Pharm Sci. 2020;33(5):2187-92.
  8. Ilyas U, Altaf R, Aun Muhammad S, Qadir MI, Nadeem H, Ahmed S. Computational drug designing of newly synthesized triazoles against potential targets of methi- cillin resistant Staphylococcus aureus. Pak J Pharm Sci. 2017;30(6):2271-9.
  9. Qadir MI, Mushtaq H, Mobeen T. In-silico study of potential carboxylic acid derivatives as D-glutamate ligase inhibitors in Salmonella typhi. Kuwait J Sci. 2018;45(1):100-7.
  10. Qadir MI. Qadirvirtide. Pak J Pharm Sci. 2011;24(4):593-5.
  11. Ameen S, Qadir MI, Ahmad B. Pharmacogenomic ap- proaches in the treatment of breast cancer by tamoxifen. Pak J Pharm Sci. 2012;25(2):469-76.
  12. Iqbal MZ, Qadir MI, Hussain T, Janbaz KH, Khan YH, Ahmad B. Probiotics and their beneficial effects against various diseases. Pak J Pharm Sci. 2014;27(2):405-15.
  13. Ahmed B, Rasul A, Tareen KZ, Hamid Akash MS, Mu- hammad SA, Irfan M, Abbas K, Qadir MI. Contemporary evidence on the dynamic role of probiotics in liver dis- eases. Pak J Pharm Sci. 2019;32(6):2759-64.
  14. Bokhari TH, Hina S, Ahmad M, Iqbal M, Shafiq M, Ar- shad M, Asghar M, Aslam M, Qadir M. Concentration of 188 Re-perrhenate for therapeutic radiopharmaceuticals. J Chem Soc Pak. 2012;35:147-50.
  15. Ali M, Hanif M, Farooqi AA. Epigenetic therapy for can- cer. Pak J Pharm Sci. 2015;28(3):1023-32.
  16. Paracha UZ, Hayat K, Ali M, Qadir MI. New diagnostic and therapeutic avenues for mesothelioma. Pak J Pharm Sci. 2015;28(4):1425-32.
  17. Ahmed B, Basheer R, Irfan M, Akash MSH, Muham- mad SA, Qadir MI. Molecular elucidations of hutchin- son-gilford progeria syndrome: A hope for managing horrors of premature aging in children. Pak J Pharm Sci. 2020;33(3):1179-82.
  18. Hussain L, Abbas K, Ahmed B, Baber M, Muhammad SA, Qadir MI. Analgesic and anti-inflammatory activity of aqueous-methanolic extract of Aerva javanica. Pak J Pharm Sci. 2017;30(1):213-5.
  19. Qadir MI, Abbas K, Hamayun R, Ali M. Analgesic, an- ti-inflammatory and anti-pyretic activities of aqueous eth- anolic extract of Tamarix aphylla L. (Saltcedar) in mice. Pak J Pharm Sci. 2014;27(6):1985-8.
  20. Qadir MI, Parveen A, Abbas K, Ali M. Analgesic, anti-in- flammatory and anti-pyretic activities of thymus linearis. Pak J Pharm Sci. 2016;29(2):591-4.
  21. Abbas K, Rizwani GH, Qadir MI, Younis M, Qaisar MN, Siddique FA, Aamir MN, Wazir A, Shaheer T. Herbal formulation comprised of methanol extracts of Tribulus terristris L. and Zingiber officinale roscoe has antihy- pertensive effects. Altern Ther Health Med. 2023;29(4): 234-9.
  22. Janbaz KH, Nisar U, Ashraf M, Qadir MI. Spasmolytic, bronchodilator and antioxidant activities of Erythrina su- perosa Roxb. Acta Pol Pharm. 2012;69(6):1111-7.
  23. Saleem S, Uzair M, Ahmad B, Qadir MI, Abbas K, Sid- diqui FA, Qaisar N. Cytomorphological, phytochemical, antimicrobial and antioxidant investigations of different morphological parts of Solanum xanthocarpum Schrad & Wendl. Lat Am J Pharm. 2018;37:839-48.
  24. Sadique A, Khalid SH, Asghar S, Irfan M, Qadir M. Mi- conazole nitrate microemulsion: Preparation, charac- terization and evaluation for enhancement of antifungal activity. Lat Am J Pharm. 2018;37(8):1578-86.
  25. Qadir MI, Abbas K, Tahir M, Irfan M, Raza Bukhari SF, Ahmed B, Hanif M, Rasul A, Ali M. Dengue fever: Natu- ral management. Pak J Pharm Sci. 2015;28(2):647-55.
  26. Qadir MI, Maqbool F, Maqbool A, Ali M. HIV-Plasmo- dium Co-infection: Malaria in AIDS patients. Pak J Pharm Sci. 2015;28(5):1811-7.
  27. Azam F, Ahmad B, Uzair M, Qadir MI. Leishmanicidal activity of aerial parts of Ranunculus muricatus and isola- tion of stigmasterol and beta-sitosterol as active constitu- ents. Lat Am J Pharm. 2018;37(9):1905-8.
  28. Ali M, Qadir MI, Saleem M, Janbaz KH, Gul H, Hussain L, Ahmad B. Hepatoprotective potential of Convolvu- lus arvensis against paracetamol-induced hepatotoxicity. Bangladesh J Pharmacol. 2013;8(3):300-4.
  29. Saleem M, Ahmed B, Karim M, Ahmed S, Ahmad M, Qadir MI. Hepatoprotective effect of aqueous meth- anolic extract of Rumex dentatus in paracetamol-in- duced hepatotoxicity in mice. Bangladesh J Pharmacol. 2014;9(3):284-9.
  30. Afzal S, Chaudhry B, Afzal K, Saeed J, Hakash S, Qadir M. Acetyl cholinesterase and butyryl cholinesterase in- hibitory activities of Zaleya pentandra. Acta Pol Pharm. 2017;74(3):891-4.

Cited by

Sorted by citations

Authors
Qadir, M. I., Bashir, H., & Ahmad, M. H.
Affiliations
Bahauddin Zakariya University (PK)
Venue
Critical Reviews in Immunology
Publisher
Begell House
Published
2023
Volume
43
Issue
3
Pages
15-24
ISSN
  • 0197-3355 (ISSN-L)
  • 1040-8401
OpenAlex
W4386489001
Cited by
8
References
96
Citations by year
2026: 1 · 2025: 3 · 2024: 4
FWCI
0.38
Type
journal article
Language
en
Open access
Locations
  • Critical Reviews in Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV/AIDS oral health manifestations
  • Health Sciences › Dentistry › Periodontics › Oral Health Pathology and Treatment
Keywords
oropharyngeal candidiasis, oral candidiasis, Candida albicans, Candida species, fungal infection, etiology, cell-mediated immunity, humoral immunity, granulocytes, antifungal agents, nystatin, fluconazole, amphotericin
MeSH terms
Antifungal Agents, Candida albicans, Candidiasis, Candidiasis, Oral, Humans, Fluconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review